Visitors Now:
Total Visits:
Total Stories:
Profile image
By Global Market Insights Inc.
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Global Age-related Macular Degeneration Industry – Key Companies Analysis 2016 to 2020

Tuesday, October 11, 2016 23:26
% of readers think this story is Fact. Add your two cents.

(Before It's News) adds “Global Age-related Macular Degeneration Market 2016-2020” new report to its research database. The report spread across 99 pages with table and figures in it.

The Report analysts forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.

AMD is the degeneration or disintegration of the eye’s macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.

Browse full table of contents and data tables at

The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.

The market is divided into the following segments based on geography:

The Report Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Request a sample copy at

Key vendors
 Bayer HealthCare
 F. Hoffmann-La Roche
 Regeneron Pharmaceuticals

Other prominent vendors
 Adverum Biotechnologies
 Bausch + Lomb
 Gilead Sciences
 Iconic Therapeutics
 Neurotech Pharmaceuticals
 Ohr Pharmaceutical
 Resolvyx Pharmaceuticals
 RXi Pharmaceuticals
 Sagent Pharmaceuticals
 Santen Pharmaceuticals
 Sanwa Kagaku Kenkyusho

Market driver
 Increasing reimbursement benefits for AMD drugs
 For a full, detailed list, view our report

Market challenge
 Availability of alternative therapies
 For a full, detailed list, view our report

Market trend
 Novel treatment approaches for developing AMD drugs
 For a full, detailed list, view our report

Key questions answered in this report
 What will the market size be in 2020 and what will the growth rate be?
 What are the key market trends?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the market opportunities and threats faced by the key vendors?
 What are the strengths and weaknesses of the key vendors?

Inquiry before Buying at

To receive personalized assistance, write to us @ with the report title in the subject line along with your questions or call us at +1 866-764-2150

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.